National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

yttrium Y 90 anti-CD45 monoclonal antibody AHN-12
A radioimmunoconjugate comprised of the monoclonal antibody AHN-12 conjugated to the radioisotope yttrium 90 with potential radioimmunotherapeutic activity. Yttrium Y 90 monoclonal antibody AHN-12 binds to the tyrosine phosphatase CD45, expressed on the surface of normal and malignant hematopoietic cells. After binding and internalization by CD45-expressing tumor cells, this agent may deliver a cytotoxic dose of beta radiation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:Y 90 AHN-12



Previous:Xyotax, Y-90 OctreoTher, YM598, yoshi-864, yttrium Y 90 anti-CD19 monoclonal antibody BU12
Next:yttrium Y 90 anti-CD66 monoclonal antibody BW 250/183, yttrium Y 90 anti-CEA monoclonal antibody cT84.66, yttrium Y 90 daclizumab, yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A, yttrium Y 90 DOTA monoclonal antibody HuAFP31

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov